What is American Injectables?
Based out of Tampa Bay, FL, American Injectables operates as a specialized sterile injectables development and manufacturing company. The firm focuses on providing critical services within the pharmaceutical and biotechnology supply chain, addressing the complex needs of sterile drug product formulation and production. Its market position is defined by its commitment to quality and regulatory compliance in a highly specialized niche.
How much funding has American Injectables raised?
American Injectables has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2020): $10M with participation from New Rhein Healthcare Investors LLC
Key Investors in American Injectables
New Rhein Healthcare Investors LLC
New Rhein Healthcare Investors LLC is an investment firm that likely focuses on the healthcare and pharmaceutical sectors, providing capital and strategic guidance to companies within this industry.
What's next for American Injectables?
The recent major strategic investment signals a pivotal moment for American Injectables, likely enabling expansion of its manufacturing capabilities, enhancement of its research and development pipeline, or strategic market penetration. This capital infusion is expected to accelerate the company's growth trajectory, allowing it to scale operations and potentially broaden its service offerings to meet increasing demand for sterile injectable pharmaceuticals. The company's focus on development and manufacturing positions it to capitalize on the growing biopharmaceutical market.
See full American Injectables company page
